Recherches "plusieurs pathologies"
MOST Plus
My Own Specific Treatment : A two-period, multicenter, randomized, open-label, phase II study evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with progressive locally-advanced or metastatic solid tumors
Paris
CHRISTOPHE LE TOURNEAU
Recherches "plusieurs pathologies"
SCANDARE (IC 2016-03)
Prospective biobanking study in ovarian, breast and head and neck cancer patients aiming at better understand the link between the molecular alterations of the tumor itself, its microenvironment and immune response.
Paris, Saint-Cloud
CHRISTOPHE LE TOURNEAU, CORALINE DUBOT
Recherches "plusieurs pathologies"
STARTRK-2 - GO40782
A Phase 2, Multicenter, Open-Label Study of Entrectinib for the Treatment of Locally Advanced or Metastatic NSCLC in Adult Patients with Tumors That Harbor NTRK1, NTRK2, NTRK3 or ROS1 Molecular Alterations
Paris
CHRISTOPHE LE TOURNEAU
Appareil Digestif
AAS-Lynch
Assessment of the Effect of a Daily Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
Paris
BRUNO BUECHER
Appareil Digestif
ADAGE - Prodige 34
Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over.
Saint-Cloud
AMANI ASNACIOS LECERF
Appareil Digestif
AMEBICA - Prodige 38
Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours.
Saint-Cloud
AMANI ASNACIOS LECERF
Gynécologie - Ovaires
FORWARD-1
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
Saint-Cloud
ANNE DONNADIEU
Appareil Digestif
IROCAS - PRODIGE 52
A Phase III, Randomised, International Trial Comparing mFOLFIRINOX Triplet Chemotherapy to mFOLFOX for High-risk Stage III Colon Cancer in Adjuvant Setting
Saint-Cloud
AMANI ASNACIOS LECERF
Gynécologie - Ovaires
OReO
A Phase IIIb, Randomised, Double-blind, Placebo-controlled, Multicentre Study of Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer Previously Treated With a PARPi and Responding to Repeat Platinum Chemotherapy.
Paris, Saint-Cloud
MANUEL RODRIGUES, CORALINE DUBOT